Erika Zoe Lopatynsky-Reyes

TL;DR: The first reports in the literature of local Bacillus Calmette-Guerin (BCG) scar inflammation following two different available messenger ribonucleic acid (mRNA) anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) vaccines were reported in two young healthy physicians, one from Costa Rica and another from the United States of America, with normal cell blood counts, flow cytometries, and negative for human immunodeficiency virus (HIV) as mentioned in this paper.

TL;DR: A 3-day-old newborn with meningococcal conjunctivitis and sepsis and asymptomatic carriage of N. meningitidis was identified and treated with 7 days of IV ceftriaxone and discharged with no sequelae.

TL;DR: BM by N. meningitidis is endemic in Tijuana, Mexico, and meningococcal vaccination should be seriously considered in the region, and PCV13 is currently showing high effectiveness on pneumococcal BM, and it is needed to continue active surveillance to see whether maternal screening/prophylaxis for GBS should also be introduced.

TL;DR: Following 12.3 years of active surveillance, PCV13 has shown impact on both serotype-specific and all PnPEs; however, an increase of PEs by MRSA has emerged.

TL;DR: This is the first case report of a patient with MK by Fusarium spp.